Rockwell Medical, Inc. RMTI

RMTI Company Overview

Rockwell Medical, Inc. is a U.S.-based biopharmaceutical and healthcare company focused on developing, manufacturing, commercializing, and distributing products for patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). The company operates primarily within the renal care and hemodialysis industries, supplying dialysis concentrates, dialysis-related products, and therapeutic solutions used by dialysis providers and healthcare systems. Rockwell Medical is publicly traded on the Nasdaq under the ticker RMTI.

The company’s primary revenue drivers historically have included the sale of acid and bicarbonate dialysis concentrates and ancillary dialysis products used in hemodialysis treatment. Rockwell Medical has also pursued pharmaceutical development initiatives targeting iron deficiency and anemia management associated with CKD. Its customer base includes dialysis clinics, healthcare providers, and large dialysis organizations across the United States. Rockwell Medical was founded in 1996 and evolved from a dialysis products manufacturer into a company combining commercial renal products with specialty pharmaceutical development initiatives focused on nephrology care.